23 ms·
Moreso than the gouging on pricing, I have even more of an issue with the situation where he was short in a pharma company, and lobbied the FDA to deny a drug a
by FireBeyond 10y ago
Moreso than the gouging on pricing, I have even more of an issue with the situation where he was short in a pharma company, and lobbied the FDA to deny a drug approval that they were working on, on zero medical grounds, but instead purely from the perspective of helping his short position.